Food and Drug Administration Piperazines Eli Lilly and Company New Drug Application Pharmaceutical industry Tapentadol Levofloxacin Ofloxacin FDA Fast Track Development Program Chemistry Pharmacology Organic chemistry | | New Drug Application (NDA) & Biologic License Application (BLA) Efficacy Supplement Calendar Year Approvals As of December 31, 2012 Selection Criteria: User Response: Start Date: [removed]End Date: [removed]Add to Reading ListSource URL: www.fda.govDownload Document from Source Website File Size: 56,06 KBShare Document on Facebook
|